2VE6 image
Deposition Date 2007-10-17
Release Date 2008-01-22
Last Version Date 2024-11-13
Entry Detail
PDB ID:
2VE6
Keywords:
Title:
Crystal structure of a Murine MHC class I H2-Db molecule in complex with a photocleavable peptide
Biological Source:
Source Organism:
MUS MUSCULUS (Taxon ID: 10090)
SENDAI VIRUS (Taxon ID: 11191)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.65 Å
R-Value Free:
0.29
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN D-B ALPHA CHAIN
Gene (Uniprot):H2-D1
Chain IDs:A, D, G, J
Chain Length:277
Number of Molecules:4
Biological Source:MUS MUSCULUS
Polymer Type:polypeptide(L)
Molecule:BETA-2-MICROGLOBULIN
Gene (Uniprot):B2m
Chain IDs:B, E, H, K
Chain Length:99
Number of Molecules:4
Biological Source:MUS MUSCULUS
Polymer Type:polypeptide(L)
Molecule:SENDAI VIRUS EPITOPE RESIDUES 324-332 MODIFIED AT P7
Chain IDs:C, F, I, L
Chain Length:9
Number of Molecules:4
Biological Source:SENDAI VIRUS
Primary Citation
Discovery of Cd8+ T Cell Epitopes in Chlamydia Trachomatis Infection Through Use of Caged Class I Mhc Tetramers.
Proc.Natl.Acad.Sci.USA 105 3831 ? (2008)
PMID: 18245382 DOI: 10.1073/PNAS.0711504105

Abstact

Class I MHC tetramers allow direct phenotypic identification of CD8(+) T cell populations, but their production remains laborious. A peptide exchange strategy that employs class I MHC products loaded with conditional ligands (caged MHC molecules) provides a fast and straightforward method to obtain diverse arrays of class I MHC tetramers and facilitates CD8(+) T cell epitope discovery. Here, we describe the development of photocleavable analogs of the FAPGNYPAL (SV9) epitope that bind H-2K(b) and H-2D(b) with full retention of their structural and functional integrity. We ranked all possible H-2K(b) octameric and H-2D(b) nonameric epitopes that span the genome of Chlamydia trachomatis and prepared MHC tetramers from approximately 2,000 of the highest scoring peptides by replacement of the SV9 analog with the peptide of choice. The resulting 2,000-member class I MHC tetramer array allowed the discovery of two variants of an epitope derived from polymorphic membrane protein I (PmpI) and an assessment of the kinetics of emergence and the effector function of the corresponding CD8(+) T cells.

Legend

Protein

Chemical

Disease